Abstract:The study uses COVID-19 to identify the treatment group as the difference in change of non-financial corporations (NFCs) risk management ratios over time to investigate the causal effect of the NFCs' effective risk management (ERM) practices on operational efficiency (OE). ERM was measured by solvency and liquidity ratios, while the risk management theory was developed to refine the scope of the study. The data were collected from the central bank of Indonesia to map the empirical analysis, and the difference in difference (DID) technique was used to illustrate how NFCs react to mitigate the negative impact of COVID-19 and generate OE. Specifically, a quasi-natural experiment was used to size the effect of ERM practices on corporate OE during the COVID-19 pandemic. The descriptive analysis revealed that the COVID-19 pandemic effect has been unequal across different industrial sectors. Moreover, the empirical findings showed that corporate risk management during COVID-19 is the source of structural change, which affects its existence and operational efficiency. While debt amount and age may affect corporate credit score, ERM practices led the indebted corporation to the flexibility of debt refinancing or/and restructuring, which offers them the ability to prevent bankruptcy and adapt to the changes while operating efficiently. The finding revealed evidence of the important role of long-term debt in offering protection to NFCs during the credit supply shock brought in by the COVID-19 pandemic. Furthermore, the findings show that long-term debt is negatively associated with corporate OE. This was expected given that corporations use long-term debt financing for long-term investment, while short-term debt funds the working capital. Thus, to assess the effect of debts on corporate OE, managers should consider their maturity structure, among other factors.

Capped borrower credit risk and insurer hedging during the COVID-19 outbreak

Rethinking capital structure decision and corporate social responsibility in response to COVID‐19

Pricing Extreme Mortality Risk in the Wake of the COVID-19 Pandemic

Risk Management Analysis of Commercial Banks in China under COVID-19 Pandemic

Covid-19: implications for insurer risk management and the insurability of pandemic risk

Banking systemic risk estimating of China's banking industry during the COVID-19 pandemic—based on complex network theory

One Risk, Two Debts: The Effects of Rare Disasters on Credit Markets

Vulnerabilities and resilience in insurance investing: studying the COVID-19 pandemic

Free riding and insurer carbon-linked investment

Debt rollover risk, credit default swap spread and stock returns: Evidence from the COVID-19 crisis

Gambling for Recovery? Exploring the Credit Risk of European Insurers’ Bond Portfolios during the Covid-19 Market Crash

Studying corporate liquidity and regulatory responses for economic recovery in COVID-19 crises

COVID-19 mortality risk premium and the interest rate on mortgage loans

A pandemic business interruption insurance

Did COVID‐19 change life insurance offerings?

Cap-and-trade mechanisms, green technology investment, and shadow insurance in a black swan environment

Effective risk management in the shadow of COVID-19 pandemic: The evidence of Indonesian listed corporations

Adverse impact of capital regulatory reform and policy remedy: theory and evidence

The Reduction of Credit Risk in the Health Care Industry in China: Are We Returning to the Pre-COVID-19 Era?

The Impact of COVID-19 Pandemic on the Effectiveness of the CAPM Model: Evidence from the Chinese Market and Pharmaceutical Industry

Identifying policy determinants of bank default risk during the COVID-19 pandemic: empirical evidence from the U.S. and Canada